Product Recall Alerts: CVS pulls Zantac and generics as recall spreads around the globe

“This action is being taken out of an abundance of caution due to a recent Product Alert from the U.S. Food and Drug Administration (FDA) that ...
Read more: CVS pulls Zantac and generics as recall spreads around the globe

Pharma Reviews: CNBCTV18's top stocks to watch out for on October 1

Reliance Industries: Saudi Arabia has assured Mukesh Ambani's Reliance .... Indian pharma companies continue to struggle with monetisation of ...
Read more: CNBCTV18's top stocks to watch out for on October 1

Pharma Reviews: Market Live: Nifty opens above 11500, Sensex up 200 pts; BPCL gains 7%

Market Live: Nifty opens above 11,500, Sensex up 200 pts; BPCL gains 7% .... Indian Pharma cos continue to struggle with monetisation of specialty ...
Read more: Market Live: Nifty opens above 11500, Sensex up 200 pts; BPCL gains 7%

US FDA News: Statement on measuring the progress being made through implementing the FDA Food Safety Modernization Act

New performance measures show progress being made in implementing the Food Safety Modernization Act
Read more: Statement on measuring the progress being made through implementing the FDA Food Safety Modernization Act

US FDA News: FDA and DEA warn website operators illegally selling opioids

FDA and DEA issued joint warning letters to online networks illegally marketing unapproved and misbranded versions of opioids that are potentially dangerous.
Read more: FDA and DEA warn website operators illegally selling opioids

US FDA News: Statement on continued efforts to evaluate materials in medical devices to address potential safety questions

FDA announces next steps the agency is taking as part of its ongoing work to better evaluate the safety of specific materials used in medical devices. This includes holding our first public advisory committee meeting to convene experts and the public on this issue and providing new information on sc
Read more: Statement on continued efforts to evaluate materials in medical devices to address potential safety questions

Pharma Reviews: Mylan to invest $1 billion in India over next six years

Hyderabad: Multinational drug company Mylan has said it will invest $1 billion in the next 5-6 years on Capex in India, given the importance of the ...
Read more: Mylan to invest $1 billion in India over next six years

Pharma Reviews: Mylan to invest $1 billion in India on capex in 6 years

Hyderabad: Multinational drug company Myaln has said it will invest $1 billion in the next 5-6 years on capex in India, given the importance of the ...
Read more: Mylan to invest $1 billion in India on capex in 6 years

Pharma Reviews: Mylan to invest $1 billion in India on capex in 6 years

HYDERABAD: Multinational drug company Mylan has said it will invest USD one billion in the next 5-6 years on Capex in India, given the importance ...
Read more: Mylan to invest $1 billion in India on capex in 6 years

Pharma Reviews: Eywa aims to make mark in US market with own label, skip generic trend

It also wanted to be a front-end generic pharma company, which sells products with its own label, while most Indian companies looked at back-end ...
Read more: Eywa aims to make mark in US market with own label, skip generic trend

Product Recall Alerts: USFDA alert on ranitidine: No major impact on exports yet, says Pharmexcil

Leading drugmakers such as Dr Reddy's and GSK have recalled their versions of the drug in some markets, and many smaller players, both in the ...
Read more: USFDA alert on ranitidine: No major impact on exports yet, says Pharmexcil

Product Recall Alerts: GSK to recall Ranitidine from India after regulator alert

GSK has been contacted by the Indian drug regulatory authority regarding the detection of genotoxic nitrosamine NDMA in Ranitidine products.
Read more: GSK to recall Ranitidine from India after regulator alert

US FDA News: FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels

FDA approves Rituxan (rituximab) injection to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children ages 2 and older in combination with steroid hormones. It is the first approved treatment for children with these rare vasculitis diseases.
Read more: FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels

Pharma Reviews: Glenmark Pharmaceuticals Secures its Position in the Prestigious Dow Jones Sustainability ...

Glenmark is ranked 15th among the companies in pharmaceuticals, ... Glenmark is one of the only two companies from Indian Pharmaceutical sector ...
Read more: Glenmark Pharmaceuticals Secures its Position in the Prestigious Dow Jones Sustainability ...

Pharma Reviews: India: Decisions In The 37th GST Council Meeting

Machine job work in the engineering industry (other than bus bodybuilding) ... Specified R&D services provided by Indian pharma companies;; R&D ...
Read more: India: Decisions In The 37th GST Council Meeting

Pharma Reviews: Glenmark Pharmaceuticals Secures its Position in the Prestigious Dow Jones Sustainability ...

Glenmark is one of the only two companies from Indian Pharmaceutical sector to be featured in the DJSI, Emerging Markets 2019. Glenmark is ranked ...
Read more: Glenmark Pharmaceuticals Secures its Position in the Prestigious Dow Jones Sustainability ...

Pharma Reviews: Top 10 richest Indian entrepreneurs: the eighth IIFL Wealth Hurun India Rich List 2019

IIFL Wealth Hurun India Rich List 2019 was released on 25th September. Over 953 individuals crossed the Rs.1,000 crore threshold to make it to the ...
Read more: Top 10 richest Indian entrepreneurs: the eighth IIFL Wealth Hurun India Rich List 2019

US FDA News: Statement on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight

Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight
Read more: Statement on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight

Pharma Reviews: Glenmark Pharmaceuticals Secures its Position in the Prestigious Dow Jones Sustainability ...

Glenmark is among the only 12 companies from India and one of the two companies from the pharmaceutical sector to be listed in the DJSI Emerging ...
Read more: Glenmark Pharmaceuticals Secures its Position in the Prestigious Dow Jones Sustainability ...

Pharma Reviews: Traders' Diary: Add quality stocks on dips

Today's market strength was led by metals and banking stocks. .... a day after India's drug regulator asked pharma companies to check their products ...
Read more: Traders' Diary: Add quality stocks on dips

Pharma Reviews: Labelexpo Europe 2019: Avery Dennison's push at 'making a material difference' for the label ...

And finally, the product for pharma packaging, Bhardwaj, said would be of interest to the Indian converters. The Indian pharmaceutical industry has ...
Read more: Labelexpo Europe 2019: Avery Dennison's push at 'making a material difference' for the label ...

Product Recall Alerts: Popular drug ranitidine recalled after carcinogenic qualities confirmed

Popular drug ranitidine recalled after carcinogenic qualities confirmed ... alert, stating it was testing ranitidine products from multiple manufacturers.
Read more: Popular drug ranitidine recalled after carcinogenic qualities confirmed

Pharma Reviews: Govt may move drugs made from local APIs out of price control list

“What the government is considering is that if an Indian company manufactures a tablet made from a locally-manufactured API (active pharmaceutical ...
Read more: Govt may move drugs made from local APIs out of price control list

Pharma Reviews: GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos

The company sources the Ranitidine active pharmaceutical ingredient (API) from Saraca Laboratories and SMS Lifesciences for supply to the Indian ...
Read more: GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos

US FDA News: Remarks prepared for testimony before a U.S. House Energy and Commerce Subcommittee on FDA Regulation of Electronic Nicotine Delivery Systems and Investigation of Vaping Illnesses

Remarks from Acting FDA Commissioner Ned Sharpless, M.D. as prepared for testimony before a U.S. House Energy and Commerce Subcommittee on FDA Regulation of Electronic Nicotine Delivery Systems and Investigation of Vaping Illnesses
Read more: Remarks prepared for testimony before a U.S. House Energy and Commerce Subcommittee on FDA Regulation of Electronic Nicotine Delivery Systems and Investigation of Vaping Illnesses

Pharma Reviews: Top 10 biz headlines: US-India trade deal, merger of insurers, and more

Analysts, however, feel the impact on Indian formulation makers will not be high as the drug market size in the US is relatively small, around $50 ...
Read more: Top 10 biz headlines: US-India trade deal, merger of insurers, and more

Pharma Reviews: Ranitidine under lens after carcinogen alert

In India, a host of companies including GalxoSmithKline, JB Chemicals, Cadila Pharma, Zydus Cadila, Dr Reddy's, Sun Pharmaceuticals sell over 180 ...
Read more: Ranitidine under lens after carcinogen alert

Pharma Reviews: Infosys is world's third best regarded company

As many as 17 Indian companies, including Infosys, TCS and HDFC, have ... Indian companies Tata Consultancy Services (22nd position) and Tata ... Sun Pharma Industries (217), General Insurance Corporation Of India (224), ITC ...
Read more: Infosys is world's third best regarded company

Pharma Reviews: Indian firms unlikely to be hit by USFDA's red flag on antacid medicines

After high blood pressure drug (sartan), the same carcinogenic impurity is back to haunt the global pharma industry once again, this time for antacid ...
Read more: Indian firms unlikely to be hit by USFDA's red flag on antacid medicines

Pharma Reviews: A look at how InnAccel is trying to save patients from Ventilator Acquired Pneumonia

InnAccel launched the device in India, and plans to take it to overseas ... The medical device industry in India is presently valued at $5.2 Billion and is ...
Read more: A look at how InnAccel is trying to save patients from Ventilator Acquired Pneumonia

Pharma Reviews: Nasscom inks pact with China's I-Campus for healthcare innovation

Noida (UP), Sep 24 (PTI) Apex software industry body Nasscom on ... Wuxi National High-tech District and Indian bio-pharma company AstraZeneca.
Read more: Nasscom inks pact with China's I-Campus for healthcare innovation

Pharma Reviews: Amtek Auto: Supreme Court Allows RP, CoC to Invite Fresh Bids within 31 Days

While explaining the role played by the US Food and Drug Administrator (US FDA) in curtailing data fudging and malpractices in Indian pharma sector, ...
Read more: Amtek Auto: Supreme Court Allows RP, CoC to Invite Fresh Bids within 31 Days

US FDA News: FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. This is the
Read more: FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

Pharma Reviews: Anti-acidity drug ranitidine gives heartburn to industry and public

The Indian drug regulator and the Indian Medical Association are yet to come up with a warning to public and manufacturers. Swiss drug maker ...
Read more: Anti-acidity drug ranitidine gives heartburn to industry and public

US FDA News: Statement on FDA efforts to encourage patient engagement in medical device clinical investigations

FDA releases draft guidance providing our proposed recommendations for manufacturers to engage patients in multiple aspects of medical device clinical investigation design
Read more: Statement on FDA efforts to encourage patient engagement in medical device clinical investigations

Pharma Reviews: Why Dipan Mehta thinks this market rally can be sustained

The price erosion also has significantly reduced and Indian pharma companies are now trying to focus on profitable products, profitable geographies ...
Read more: Why Dipan Mehta thinks this market rally can be sustained

US FDA News: Statement on final guidance to help advance development of novel treatments for ALS

Statement on final guidance to help advance development of novel treatments for ALS
Read more: Statement on final guidance to help advance development of novel treatments for ALS

Pharma Reviews: Why an India-US Free Trade Agreement Would Require New Delhi to Reorient Key Policies

Modi should use trade talks to draw a red line around India's critical ... The petitions were filed by the US dairy industry and the US medical device ...
Read more: Why an India-US Free Trade Agreement Would Require New Delhi to Reorient Key Policies

Pharma Reviews: How plastic ban will affect businesses and consumers

India's plastic-processing industry has over 30,000 units and an annual ... consumer goods (FMCG) and pharma companies — are supposed to take ...
Read more: How plastic ban will affect businesses and consumers

Pharma Reviews: GST Council reduces rates on Hotel tariffs; hikes tax on caffeinated beverages

Rate reduction sector-wise: ... Clinical trials,Bioanalytical studies) provided by Indian pharma companies to foreign service recipients, as the place of ...
Read more: GST Council reduces rates on Hotel tariffs; hikes tax on caffeinated beverages

Pharma Reviews: India Industry suggests Govt to follow structured approach to ban single-use plastic; exempt some ...

“CII (Confederation of Indian Industry) supports the phase-out of single-use ... It has suggested that plastic packaging/bottles used for pharma/health ...
Read more: India Industry suggests Govt to follow structured approach to ban single-use plastic; exempt some ...

Pharma Reviews: Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster ...

New Delhi: Healthcare industry on Friday welcomed the government's ... Also Read: Indian pharma industry may achieve double-digit growth by 2030 ...
Read more: Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster ...

Pharma Reviews: A Gujarati will set up first pharma unit in J&K, says Union minister

I also look after the pharmaceutical department, as well as chemicals and ... The local residents will also feel that they are part of India. Administrative ...
Read more: A Gujarati will set up first pharma unit in J&K, says Union minister

Pharma Reviews: A Gujarati will set up first pharma unit in Kashmir, says MoS Mandaviya

A Gujarati will set up first pharma unit in Kashmir, says MoS Mandaviya ... I also look after the pharmaceutical department, as well as chemicals and ... Mandaviya also claimed that foreigners who come to India now visit Delhi's ...
Read more: A Gujarati will set up first pharma unit in Kashmir, says MoS Mandaviya

Pharma Reviews: GST Council announces reduced rates on various services

Rate reduction sector wise: ... Exemption sector wise: ... Clinical trials, Bio analytical studies) provided by Indian pharma companies to foreign service ...
Read more: GST Council announces reduced rates on various services

Pharma Reviews: As Modi Visits US, What Does the Free Trade Pact Mean for India's Pharma Industry?

A Free Trade Agreement with the US will likely result in the amendment of the Patents Act, which could impact the Indian pharma industry.
Read more: As Modi Visits US, What Does the Free Trade Pact Mean for India's Pharma Industry?

Pharma Reviews: Pharma talks: Govt urged to safeguard public health

Over the last few weeks, US pharmaceutical corporations have reportedly been lobbying with the Indian government to give up major health ...
Read more: Pharma talks: Govt urged to safeguard public health

Pharma Reviews: GST reduced on hotel accommodation, outdoor catering

... bio-equivalence and bio-availability studies, clinical trials, bio analytical studies) provided by Indian pharma companies to foreign service recipients.
Read more: GST reduced on hotel accommodation, outdoor catering

Pharma Reviews: GST Council Recommends reduced GST Rate on Services

Rate reduction sector wise: ... Clinical trials, Bio analytical studies) provided by Indian pharma companies to foreign service recipients, as the place of ...
Read more: GST Council Recommends reduced GST Rate on Services

Pharma Reviews: The continuing vulnerability of health data

For the pharmaceutical sector in India, cybersecurity is weaker than it ought to be: a mere five to ten percent of pharmaceutical companies in the ...
Read more: The continuing vulnerability of health data

Pharma Reviews: Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs ...

The Hyderabad Pharma City project has received an overwhelming ... China province eyeing investment opportunities in an Indian medical sector.
Read more: Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs ...

US FDA News: Statement on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths

Statement on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths
Read more: Statement on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths

US FDA News: FDA approves first oral GLP-1 treatment for type 2 diabetes

FDA approves Rybelsus (semaglutide) oral tablets to improve blood sugar in adults with type 2 diabetes, with diet and exercise. It is first GLP-1 receptor protein treatment approved in U.S.
Read more: FDA approves first oral GLP-1 treatment for type 2 diabetes

US FDA News: FDA issues proposed rule for premarket tobacco product applications as part of commitment to continuing strong oversight of e-cigarettes and other tobacco products

FDA issues proposed rule for premarket tobacco product applications as part of commitment to continuing strong oversight of e-cigarettes and other tobacco products
Read more: FDA issues proposed rule for premarket tobacco product applications as part of commitment to continuing strong oversight of e-cigarettes and other tobacco products

Pharma Reviews: Pharma logistics stakeholders take ownership of compliance, data, and training of people

September 20, 2019: The third edition of the Global Pharma Logistics ... The cross-industry event organised by Indian Transport and Logistics News, ...
Read more: Pharma logistics stakeholders take ownership of compliance, data, and training of people

Pharma Reviews: AstraZeneca strengthens partnership with NASSCOM to fight NCDs

... and Mr. Gagan Singh, Managing Director, AstraZeneca Pharma India Ltd. ... “Advanced technology adoption in Indian healthcare sector is poised for ...
Read more: AstraZeneca strengthens partnership with NASSCOM to fight NCDs

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death

Pharma Reviews: Delhivery joins Pharma.Aero at Global Pharma Logistics Summit Mumbai

Aero Frank Van Gelder before a large delegation of logistics and supply chain professionals representing Indian pharma manufacturers and logistic ...
Read more: Delhivery joins Pharma.Aero at Global Pharma Logistics Summit Mumbai

US FDA News: FDA continues to take steps to fulfill its commitment to strengthen and modernize the 510(k) medical device program

FDA is issuing draft guidances outlining recommended premarket performance criteria and testing methodologies for four specific types of devices under the Safety and Performance Based Pathway for medical devices.
Read more: FDA continues to take steps to fulfill its commitment to strengthen and modernize the 510(k) medical device program

Pharma Reviews: NASSCOM, AstraZeneca strengths collaboration towards driving digital healthcare

The forum is one of the largest neutral eco-systems comprising stakeholders from pharma industry, medtech companies, health insurance organisations, ... Government of Sweden and Gagan Singh, MD, AstraZeneca Pharma India.
Read more: NASSCOM, AstraZeneca strengths collaboration towards driving digital healthcare

Pharma Reviews: Top 10 biz headlines: Advance tax collection, Bakshi's deal, and more

Stocks of multinational pharmaceutical companies have outclassed their Indian peers this year, and chances are they could continue to maintain their ...
Read more: Top 10 biz headlines: Advance tax collection, Bakshi's deal, and more

Pharma Reviews: Industry an important pillar for growth of the healthcare sector: Sadananda Gowda

While inaugurating PharmaMed, D. V. Sadananda Gowda, Minister of Chemicals & Fertilizers said, “Indian industry can give a big push to the growth ...
Read more: Industry an important pillar for growth of the healthcare sector: Sadananda Gowda

Pharma Reviews: TPG to focus on pharma, will still back hospitals

A record 140 million Indian households expected to enter the middle class in ... Elaborating on its strategy to invest in API companies, the firm believes ... “Pharma companies will get more and more specialised and stick to their core.
Read more: TPG to focus on pharma, will still back hospitals

Pharma Reviews: 40 million jobs to be created by healthcare industry within 2020: Sadananda Gowda

"The Indian healthcare industry is one of the most knowledgeable and ... The Minister said Indian pharmaceutical industry supplies over 50 per cent of ...
Read more: 40 million jobs to be created by healthcare industry within 2020: Sadananda Gowda

Pharma Reviews: Indian healthcare industry to employ millions by 2020: Minister Gowda

The PHD Chamber of Commerce and Industry said the Indian pharmaceutical industry has been growing steadily, attracting the interests of domestic ...
Read more: Indian healthcare industry to employ millions by 2020: Minister Gowda

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions

FDA issues revised guidance to allow for a more efficient approach to 505(q) petitions and focus more resources on scientific reviews.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions

Pharma Reviews: Indian healthcare sector to surge threefold at a CAGR of 22% during 2016-2022: Minister of ...

Though we are dependent on imports in medical devices but Indian Medical Device manufacturers have now taken a lead and are producing high ...
Read more: Indian healthcare sector to surge threefold at a CAGR of 22% during 2016-2022: Minister of ...

Pharma Reviews: Demand for anti-infectives aside, pharma sales are under pressure

Indian pharmaceutical companies are benefiting from a rise in vector-borne diseases. Domestic revenues rose 9.4% last month, primarily driven by the ...
Read more: Demand for anti-infectives aside, pharma sales are under pressure

Pharma Reviews: CNBC-TV18 Market Highlights: Indices see sell-off across sectors on macro worries, Sensex drops ...

-Market sees a major sell-off, Nifty erases 2019 gains. ..... "The Indian pharma industry's strongest market that drives half the revenues is the United ...
Read more: CNBC-TV18 Market Highlights: Indices see sell-off across sectors on macro worries, Sensex drops ...

Pharma Reviews: Sitharaman hands over antique bronze idol of Buddha to Culture Minister

The Indian healthcare sector is expected to record a threefold rise, at a ... Conference "Pharma Med HD 2019 Transforming the perception of Indian ...
Read more: Sitharaman hands over antique bronze idol of Buddha to Culture Minister

Pharma Reviews: Health care industry expected to generate 40 million jobs by 2020: Sadananda Gowda

"Though we are dependent on imports in medical devices but Indian Medical Device manufacturers have now taken a lead and are producing ...
Read more: Health care industry expected to generate 40 million jobs by 2020: Sadananda Gowda

Pharma Reviews: Cyberattacks: A crisis in Indian pharma?

The pharmaceutical sector in India is the sixth most-affected industry of its kind in the world in terms of cyberattacks. Attempted malicious attacks hit ...
Read more: Cyberattacks: A crisis in Indian pharma?

Pharma Reviews: Indian pharma players shifting to specialty business due to pricing pressure in US: Nirmal Bang

"The Indian pharma industry's strongest market that drives half the revenues is the United States. The generic players, for years, have been relying on ...
Read more: Indian pharma players shifting to specialty business due to pricing pressure in US: Nirmal Bang

US FDA News: FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma

Project Orbis provides a framework for concurrent submission and review of oncology drugs among its international partners. Under this project, the FDA, Australia and Canada collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in all three countries.
Read more: FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma

Pharma Reviews: India ranks 6th for highest cyber attacks on pharma firms

New Delhi: India is the sixth country in the world where more and more pharmaceutical companies are being targeted by cyber criminals, a new report ...
Read more: India ranks 6th for highest cyber attacks on pharma firms

Pharma Reviews: Pharma wrap: Ranitidine carcinogen impurity scare and rising problem of drug contamination

China supplies most of the key starting materials and active pharmaceutical ingredients to Indian companies. Indian firms then formulate it and export ...
Read more: Pharma wrap: Ranitidine carcinogen impurity scare and rising problem of drug contamination

Pharma Reviews: India again lobbies with Beijing to sell its generic medicines amid US-China trade war

New Delhi: In the midst of increasing trade tension between the US and China, India has made another attempt to gain access in the Chinese market ...
Read more: India again lobbies with Beijing to sell its generic medicines amid US-China trade war

Pharma Reviews: Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20

Director-general of Pharmexcil, a body under the Ministry of Commerce and Industry, Uday Bhasker said some of the policy decisions being taken by ...
Read more: Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20

Pharma Reviews: RCEP: Why India softened its stand on a mega trade deal

Consider India's pharma industry, dominated by branded generics, which exports nearly as much as it supplies to the domestic market. In 2009 ...
Read more: RCEP: Why India softened its stand on a mega trade deal

Pharma Reviews: Indian Pharma Exports Surge 11 Percent in First Quarter; See 21 Percent Jump In July

Even as most other sectors in the economy are gripped in a stage of slowdown, the Indian pharmaceuticals sector has registered a stellar growth of 11 ...
Read more: Indian Pharma Exports Surge 11 Percent in First Quarter; See 21 Percent Jump In July

Pharma Reviews: Pharma exports may touch $22 billion in FY20: R Uday Bhaskar, director-general, Pharmexcil

Despite slowdown across industries, the Indian pharmaceutical sector is upbeat on exports following the signs of revival in the US market. Drug prices ...
Read more: Pharma exports may touch $22 billion in FY20: R Uday Bhaskar, director-general, Pharmexcil

US FDA News: Zantac (ranitidine): Safety Information - NDMA Found in Samples of Some Ranitidine Medicines

FDA has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain NDMA.
Read more: Zantac (ranitidine): Safety Information - NDMA Found in Samples of Some Ranitidine Medicines

Pharma Reviews: Pharma industry eyes global growth

Hyderabad: India's pharmaceuticals industry which recorded $19.2 billion exports during 2018-19 comprising of bulk drugs, finished dosage ...
Read more: Pharma industry eyes global growth

Pharma Reviews: Pharmexcil sees pharma exports at $22 billion in FY20

"As of June 2019, India's generic pharmaceutical exports have grown almost 2.7 to 2.8 times faster than the market (global generic market). Hence, we ...
Read more: Pharmexcil sees pharma exports at $22 billion in FY20

Pharma Reviews: Indian pharma exports may touch $22 bn in FY '20: Pharmexcil

The cumulative growth of Indian exports for the period April-July was 13 per cent. As of June 2019, India's generic pharmaceutical exports have grown ...
Read more: Indian pharma exports may touch $22 bn in FY '20: Pharmexcil

Pharma Reviews: Indian pharmaceuticals exports may touch $22 bn in FY '20: Pharmexcil

Pinning hopes on the recovery of the USA market, a top official of the Pharmaceuticals Export Promotion Council of India (Pharmexcil)on Friday said ...
Read more: Indian pharmaceuticals exports may touch $22 bn in FY '20: Pharmexcil

Pharma Reviews: 'Pharma exports expected to touch $22 billion in FY20'

Hyderabad: Pinning hopes on the recovery of the USA market, a top official of the Pharmaceuticals Export Promotion Council of India (Pharmexcil)on ...
Read more: 'Pharma exports expected to touch $22 billion in FY20'

Product Recall Alerts: 5 ways traceability technologies can lead to a safer, more sustainable world

Pharmaceutical industry ... Should a device be recalled, a traceability solution will alert the user at any stage of the supply chain, eliminating a ...
Read more: 5 ways traceability technologies can lead to a safer, more sustainable world

US FDA News: Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib): Drug Safety Communication - Due to Rare but Severe Lung Inflammation

FDA is warning that Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib) used to treat some patients with advanced breast cancers may cause rare but severe inflammation of the lungs.
Read more: Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib): Drug Safety Communication - Due to Rare but Severe Lung Inflammation

US FDA News: Statement alerting patients and health care professionals of NDMA found in samples of ranitidine

The U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels.
Read more: Statement alerting patients and health care professionals of NDMA found in samples of ranitidine

Pharma Reviews: Indian pharma exports to touch $22 billion this fiscal, Q1 exports stand at $5 billion

HYDERABAD: Indian pharmaceutical exports are likely to touch $22 billion this fiscal largely owing to improving exports to and stabilising prices in the ...
Read more: Indian pharma exports to touch $22 billion this fiscal, Q1 exports stand at $5 billion

Pharma Reviews: Stocks to watch: HUL, Biocon, M&M, Dr Reddy's, autos, Adani Transmission

Biocon: India's largest bio-pharmaceutical major Biocon has entered a licence and supply pact with a subsidiary of China Medical System (CMS) for ...
Read more: Stocks to watch: HUL, Biocon, M&M, Dr Reddy's, autos, Adani Transmission

Pharma Reviews: India: Gujarat – A Re-emerging Pharma Destination?

Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company, the Alembic ...
Read more: India: Gujarat – A Re-emerging Pharma Destination?

Pharma Reviews: Why Abbot India Outperformed Pharma Peers

By comparison, the benchmark Nifty Pharma Index fell nearly 9 and the drugmaker's most Indian peers declined. The company's outperformance can ...
Read more: Why Abbot India Outperformed Pharma Peers

Pharma Reviews: Kashmir casts a long shadow on India-China relations

The Indian pharmaceutical industry was particularly optimistic because China seemed convinced that cheaper Indian generic medicines could drive ...
Read more: Kashmir casts a long shadow on India-China relations

Pharma Reviews: US-China trade war offers opportunity for Indian manufacturers in export markets: Piyush Goyal

India needs to work on its strengths by exploring market access for agriculture and pharma products in different regions," he said while addressing the ...
Read more: US-China trade war offers opportunity for Indian manufacturers in export markets: Piyush Goyal

Pharma Reviews: Enabling secure supply chain management for clinical trials

Indian pharmaceutical companies are facing a unique set of challenges that are creating significant pressure to transform their supply chain ...
Read more: Enabling secure supply chain management for clinical trials

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms

Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms

US FDA News: FDA conducts major global operation to protect consumers from potentially dangerous prescription drugs sold online

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved versions of prescription medicines, including opioids, antibiotics and injectable epinephrine products to American consumers.
Read more: FDA conducts major global operation to protect consumers from potentially dangerous prescription drugs sold online

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s Adverse Event Reporting System (FAERS) and new search tool

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s Adverse Event Reporting System (FAERS) and new search tool
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s Adverse Event Reporting System (FAERS) and new search tool

US FDA News: FDA approves new antibacterial drug

The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
Read more: FDA approves new antibacterial drug

US FDA News: FDA approves new drug to treat multiple sclerosis

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by the FDA for PPMS. Ocrevus is an intravenous infusion given by a health care professional.
Read more: FDA approves new drug to treat multiple sclerosis

US FDA News: FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children & nursing mothers

The health and safety of children is a top priority at the FDA, which is why today we are requiring a series of changes to the labeling of two types of opioid medications in order to help better protect children from serious risks associated with these medicines – codeine (found in some prescription pain and cough medicines and some over-the-counter cough medicines) and tramadol (found in some prescription pain medicines).
Read more: FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children & nursing mothers

US FDA News: La FDA aprueba el Eucrisa para el eccema

El día de hoy, la Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) de los Estados Unidos aprobó el ungüento Eucrisa (crisaborola) para el tratamiento del eccema de leve a moderado (dermatitis atópica) en pacientes de dos años de edad en adelante.
Read more: La FDA aprueba el Eucrisa para el eccema

US FDA News: FDA grants accelerated approval to new treatment for advanced ovarian cancer

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.
Read more: FDA grants accelerated approval to new treatment for advanced ovarian cancer

US FDA News: FDA approves first drug to treat tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
Read more: FDA approves first drug to treat tardive dyskinesia

US FDA News: FDA and EPA issue final fish consumption advice

Today, the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency issued final advice regarding fish consumption. This advice is geared toward helping women who are pregnant or may become pregnant – as well as breastfeeding mothers and parents of young children – make informed choices when it comes to fish that are healthy and safe to eat. (This advice refers to fish and shellfish collectively as “fish.”)
Read more: FDA and EPA issue final fish consumption advice

US FDA News: FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about which antibiotics the organism is likely to respond to (antibiotic sensitivity).
Read more: FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

US FDA News: FDA approves new psoriasis drug

The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.
Read more: FDA approves new psoriasis drug

US FDA News: FDA approves new eczema drug Dupixent

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Dupixent can be used with or without topical corticosteroids.
Read more: FDA approves new eczema drug Dupixent

US FDA News: FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders

FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders
Read more: FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders

US FDA News: La FDA amplía la indicación de un sistema de control continuo de la glucosa, el primero en reemplazar la prueba de punción capilar para la toma de decisiones en el tratamiento de la diabetes

El día de hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) amplió el uso aprobado del Sistema Móvil de Control Continuo de la Glucosa G5, de Dexcom, con el fin de permitir el reemplazo de la prueba de medición de la glucosa (azúcar) en la sangre por punción capilar (o digital) para la toma de decisiones en el tratamiento de la diabetes en personas diabéticas de 2 años de edad en adelante. Éste es el primer sistema de control continuo de la glucosa aprobado por la FDA que puede usarse para tomar decisiones relacionadas con el tratamiento de la diabetes sin necesidad de confirmar con una prueba de punción tradicional. El sistema fue aprobado previamente como un complemento, pero no reemplazo, de la prueba de punción capilar para la toma de decisiones en el tratamiento de la diabetes.
Read more: La FDA amplía la indicación de un sistema de control continuo de la glucosa, el primero en reemplazar la prueba de punción capilar para la toma de decisiones en el tratamiento de la diabetes

US FDA News: FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
Read more: FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

US FDA News: FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
Read more: FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

US FDA News: FDA approves Trulance for Chronic Idiopathic Constipation

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.
Read more: FDA approves Trulance for Chronic Idiopathic Constipation

US FDA News: FDA approves Xermelo for carcinoid syndrome diarrhea

The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.
Read more: FDA approves Xermelo for carcinoid syndrome diarrhea

US FDA News: FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions

The U.S. Food and Drug Administration today expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Read more: FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions

US FDA News: FDA approves drug to treat Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system.
Read more: FDA approves drug to treat Duchenne muscular dystrophy

US FDA News: FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy

The U.S. Food and Drug Administration today allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of underdeveloped breasts and soft tissue deformities. A patient uses a dose controller to independently inflate the expander.
Read more: FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy

US FDA News: FDA approves first drug for spinal muscular atrophy

FDA approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord.
Read more: FDA approves first drug for spinal muscular atrophy

Pharma Reviews: Apple Event 2019, Paytm Net Loss Jumps by 165%, UK Parliament Suspension Kicks Off

That's Pharma-tastic: If the June quarter numbers are any indication, Indian pharmaceutical firms are getting back on their feet. Q1 FY20 revenues of ...
Read more: Apple Event 2019, Paytm Net Loss Jumps by 165%, UK Parliament Suspension Kicks Off

Pharma Reviews: Why Himachal Pradesh may allow controlled cannabis cultivation

Israel, Canada and Malaysia have reportedly approached the state government to provide cannabis extract for use in the pharma industry. The hemp ...
Read more: Why Himachal Pradesh may allow controlled cannabis cultivation

Pharma Reviews: India, China to cooperate in RnD for promoting Indian generic drugs, Chinese APIs

The working group on pharmaceuticals decided that both sides should ... Indian generic drugs and Chinese APIs (raw material for pharma sector).
Read more: India, China to cooperate in RnD for promoting Indian generic drugs, Chinese APIs

Pharma Reviews: India, China to cooperate in solar cell R&D for developing new tech

India, China to cooperate in solar cell R&D for developing new tech ... Indian generic drugs and Chinese APIs (raw material for pharma sector).
Read more: India, China to cooperate in solar cell R&D for developing new tech

Pharma Reviews: India, China to cooperate in R&D for developing new tech for manufacturing solar cell

New Delhi: India and China have agreed on cooperation in R&D for ... Indian generic drugs and Chinese APIs (raw material for pharma sector).
Read more: India, China to cooperate in R&D for developing new tech for manufacturing solar cell

US FDA News: Statement on improving adverse event reporting of compounded drugs to protect patients

The FDA is working to improve adverse event reporting of compounded drugs to protect patients
Read more: Statement on improving adverse event reporting of compounded drugs to protect patients

Pharma Reviews: India, China to developing new technology for manufacturing solar cell

India and China have agreed on R&D cooperation for developing new ... Indian generic drugs and Chinese APIs (raw material for pharma sector).
Read more: India, China to developing new technology for manufacturing solar cell

Pharma Reviews: India, China to cooperate in R&D for developing new tech for manufacturing solar cell

India and China have agreed on cooperation in R&D for developing new ... Indian generic drugs and Chinese APIs (raw material for pharma sector).
Read more: India, China to cooperate in R&D for developing new tech for manufacturing solar cell

US FDA News: FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth

FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth
Read more: FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth

US FDA News: Tetrahydrocannabinol (THC)-containing Vaping Products: Vaping Illnesses

Consumers are likely aware of the recent reports of respiratory illnesses – including some resulting in deaths – following the use of vaping products.The FDA is working closely with the CDC, as well as state and local public health partners to investigate them as quickly as possible.
Read more: Tetrahydrocannabinol (THC)-containing Vaping Products: Vaping Illnesses

Pharma Reviews: Indian pharmaceutical companies gain from easing pricing pressures

The June quarter results of Indian pharmaceutical firms were encouraging, reflecting that the top companies are on a path to recovery. First quarter ...
Read more: Indian pharmaceutical companies gain from easing pricing pressures

Pharma Reviews: As slowdown hits, this sector could emerge as dark horse with some help from China

The Indian pharmaceutical industry had a rough start to the year. Regulatory and pricing issues kept the sector volatile and uncertainty was the ...
Read more: As slowdown hits, this sector could emerge as dark horse with some help from China

Pharma Reviews: OPPI: A need to build an inclusive healthcare ecosystem

OPPI-BCG report released at the event, 'Leapfrogging India's health ... The National Institute of Pharmaceutical Education and Research (NIPERs), ...
Read more: OPPI: A need to build an inclusive healthcare ecosystem

Pharma Reviews: Why India's Pharma Industry Needs to Act Now to Win Back the Trust It Lost

Although the Indian pharma industry has denied these claims, Eban writes that pre-announced or inadequate inspections and data-tampering ...
Read more: Why India's Pharma Industry Needs to Act Now to Win Back the Trust It Lost

Pharma Reviews: 2010s: The decade is ending on a sour note for Indian economy

In the 1990s, Indian industry struggled in a liberalised economy. ... making India a global force, as companies in software, pharma and auto did in the ...
Read more: 2010s: The decade is ending on a sour note for Indian economy

Pharma Reviews: Whistle-blower vs Ranbaxy saga asks disturbing questions

Thakur knew that though both companies manufactured pharma products, the ... But was Ranbaxy the only Indian company guilty of manipulation?
Read more: Whistle-blower vs Ranbaxy saga asks disturbing questions

Pharma Reviews: Pakistan's quick U-turn on its trade ban on pharmaceutical products with India

Pakistan's knee-jerk decision to suspend all trade relations with India could have only created a barrier of access to medicines for the Pakistani ...
Read more: Pakistan's quick U-turn on its trade ban on pharmaceutical products with India

Pharma Reviews: Natco challenges Novartis; claims right to manufacture diabetes drug

MUMBAI: In a fresh case of confrontation between generic pharma industry ... of Indian Patent 209534 which not only discloses but also claims Vildagliptin”, ... At least 18 companies were restrained by Novartis last year in Gujarat ...
Read more: Natco challenges Novartis; claims right to manufacture diabetes drug

Pharma Reviews: Stocks To Watch: Bajaj Finance, DHFL, NDTV, Prabhat Dairy, Reliance Industries, Sun Pharma

Reliance Industries: Reliance Jio has announced the commencement of ... Sun Pharma clarified that SEBI had ordered forensic audit with respect to ... Company Law Tribunal has directed State Bank of India to maintain status quo ...
Read more: Stocks To Watch: Bajaj Finance, DHFL, NDTV, Prabhat Dairy, Reliance Industries, Sun Pharma

Pharma Reviews: India: Pharma Round Up: Key Developments In 2019

The first half of 2019 has witnessed a lot of activity in the pharma space, .... The Indian pharma industry is poised to grow exponentially in the coming ...
Read more: India: Pharma Round Up: Key Developments In 2019

Pharma Reviews: BT Buzz: Healthy Q1 results but challenges galore for Indian pharma

Most leading pharma companies such as Sun Pharma, Dr Reddy's, Lupin, Cipla, Biocon and Aurobindo Pharma concluded the June quarter on a ...
Read more: BT Buzz: Healthy Q1 results but challenges galore for Indian pharma

Pharma Reviews: Gujarat Investors' Paradise

Gujarat's economic and industrial leadership is attributed to the state's ... 53% of the total medical devices manufactured in India; 15% of India's drug ...
Read more: Gujarat Investors' Paradise

Pharma Reviews: Don't call it a bear market, there has simply been a slowdown: Prashant Jain, HDFC AMC

Even though it feels like a bear market in mid and smallcap stocks, your view ... The way Indian corporates have done business has changed in the last .... the growth rates in local markets in pharmaceutical industry has come down ...
Read more: Don't call it a bear market, there has simply been a slowdown: Prashant Jain, HDFC AMC

Pharma Reviews: How digital technologies are reshaping pharma marketing in India

MUMBAI: India holds an important position in the global pharmaceutical sector. As per an IBEF report, it is the largest provider of generic drug globally ...
Read more: How digital technologies are reshaping pharma marketing in India

Pharma Reviews: Lupin signs second partnership for its oncology pipeline, this time with German drug maker BI

Indian pharma major Lupin and German drug maker Boehringer Ingelheim ... The company did not disclose in how many patients did it test the drug.
Read more: Lupin signs second partnership for its oncology pipeline, this time with German drug maker BI

Pharma Reviews: Pakistan The Most Dangerous Country and Breeding Ground Of Radicalism – Former US ...

Rafale vs F-16's: Can The Indian Rafale Jets Overpower The Pakistani ... Initially, the pharmaceutical industry had appealed to the government to relax ...
Read more: Pakistan The Most Dangerous Country and Breeding Ground Of Radicalism – Former US ...

Pharma Reviews: Pakistan To Buy Mirage Fighter Jets From Egypt Amid Rising Tensions With India

Rafale vs F-16's: Can The Indian Rafale Jets Overpower The Pakistani .... Initially, the pharmaceutical industry had appealed to the government to ...
Read more: Pakistan To Buy Mirage Fighter Jets From Egypt Amid Rising Tensions With India

Pharma Reviews: Lifescience Firm Indegene Acquires London-based DT Associates a Pharma CX Firm

Indegene, a leading next-generation solutions organization for the Life Sciences industry globally, has entered into an agreement to acquire a majority ...
Read more: Lifescience Firm Indegene Acquires London-based DT Associates a Pharma CX Firm

Pharma Reviews: Lucrative drugs like Viagra, Humira to lose patents but Indian pharma unlikely to gain

For years, Indian companies have tapped into the US market with their generics, making the country India's largest pharma export destination.
Read more: Lucrative drugs like Viagra, Humira to lose patents but Indian pharma unlikely to gain

Pharma Reviews: Sun Pharma slides 4% on report of Sebi ordering forensic audit

Sun Pharmaceutical Industries dipped 5 per cent to Rs 416.85 apiece in ... Shares of Union Bank of India, State Bank of India, Central Bank of India, ...
Read more: Sun Pharma slides 4% on report of Sebi ordering forensic audit

Pharma Reviews: Running short of life-saving drugs, Pakistan 'exempts' pharma industry from trade ban with India

New Delhi | Jagran News Desk: Pakistan's commerce ministry, in order to avoid a severe crisis on the availability of life-saving drugs in the local ...
Read more: Running short of life-saving drugs, Pakistan 'exempts' pharma industry from trade ban with India

Pharma Reviews: Trade & Investments: India, Russia Explore New Areas to Tap the Potential

India should intensify its cooperation with Russia's Far East in the sectors of Timber, Oil & Gas, Tourism, Healthcare, Pharmaceuticals and Minerals ...
Read more: Trade & Investments: India, Russia Explore New Areas to Tap the Potential

Pharma Reviews: No Change In Nuclear First Use Policy, Imran Khan's Peace Statement Brushed Away By Pakistan ...

Initially, the pharmaceutical industry had appealed to the government to relax rules and allow Indian goods imported before the decision.
Read more: No Change In Nuclear First Use Policy, Imran Khan's Peace Statement Brushed Away By Pakistan ...

Pharma Reviews: Stocks Radar: DHFL, GSK Pharma, Indian Oil, PNB, Tata Steel

Indian stock markets opened in the red on Tuesday—the first trading session since the government announced a mega bank merger plan and data ...
Read more: Stocks Radar: DHFL, GSK Pharma, Indian Oil, PNB, Tata Steel

Pharma Reviews: Gujarat pharma prescribes win pill to world

The pharma companies had to get the WHO certification for the export market. Since the new rules adopted by India were close to the WHO norms, ...
Read more: Gujarat pharma prescribes win pill to world

Pharma Reviews: Startups seek a cure for costly medical devices

Nearly half the babies born in India, especially in rural areas and small ... He joined pharma industry veteran Siraj Dhanani seven years ago to start ...
Read more: Startups seek a cure for costly medical devices

Pharma Reviews: Pharma wrap: Purdue Pharma settlement, US opioid crisis and lessons for India

Last week, US-based Purdue Pharma and its owners, the Sackler family, offered to settle over 2,000 lawsuits against the company for $10 billion to ...
Read more: Pharma wrap: Purdue Pharma settlement, US opioid crisis and lessons for India